Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
atrial fibrillation
Pharma
BMS delays key Cobenfy, milvexian readouts amid Q2 beat
BMS lifted its full-year outlook after recording nearly $13 billion in Q2 revenue, which topped Wall Street’s consensus by 10.6%.
Angus Liu
Jul 30, 2026 10:12am
Hall of Famer assists BMS, Pfizer on Eliquis heart health push
Feb 20, 2023 11:00am
Eliquis partners BMS, Pfizer double down on heart health
Feb 17, 2022 4:52am
InCarda posts midphase data on inhaled atrial fibrillation drug
Jun 15, 2021 8:30am
BMS, Pfizer join the pharma push for doctor visits amid pandemic
Nov 2, 2020 8:21am
AliveCor's KardiaMobile teams with Olympic champion swimmer
Dec 9, 2019 8:25am
